Microplasmin Meets Primary Endpoint in Second Phase III Trial in VMA, Confirms Positive Findings of First Trial

Data Presented at ASRS Confirm Previous Phase III Findings and Microplasmin's Potential to Transform the Treatment of Retinal Disorders

LEUVEN, Belgium, September 1, 2010 – ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical
company focused on the discovery and development of innovative treatments for
eye disease, vascular disease and cancer announces that its second Phase III
trial evaluating microplasmin [...]

Amsterdam Molecular Therapeutics Reports Half-Year Results 2010

AMSTERDAM, The Netherlands, August 31, 2010 – Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field
of human gene therapy, today reported its results for the first half year of
2010.

Highlights

– Glybera(R):
– EMA initiated MAA review in 01/2010
– Approval [...]

InSightec Treats First Prostate Cancer Patients in Clinical Trials

ExAblate(R) MR Guided Focused Ultrasound System is Being Used for the First Time for Non-invasive Treatment of Prostate Cancer

TIRAT CARMEL, Israel, August 31, 2010 – InSightec Ltd., the global leader in MR guided focused ultrasound
technology and the only company to receive FDA approval for its ExAblate(R)
system for treating uterine fibroids, announced today that its [...]

PharmaVentures Appoints Paul Phull as Senior Director

New Business Development Expert Brings More Than 20 Years of Industry M&A and Licensing Experience to Strengthen Pharmaventures' Corporate Advisory Services to its Clients

OXFORD, England, August 31, 2010 – PharmaVentures Ltd (www.pharmaventures.com) ("PharmaVentures")
today announced that Paul Phull has joined the company as Senior Director.
With more than 24 years of senior level commercial, business/corporate
development and [...]

Serono Symposia International Foundation (SSIF) Launches a New Web Site Dedicated to Medical Education on Phenylketonuria (PKU)

A New Tool is Targeted to Specialists in PKU, Offering an Advanced Educational Pathway Consisting of CME Accredited e-Learning Modules

ROME, August 31, 2010 – PKU specialists around the world can now count on a brand-new,
authoritative website entirely dedicated to this rare genetic disorder, which
affects one out of every 10,000 to 20,000 live births worldwide.

[...]

Frost & Sullivan Applauds the Lodox Statscan Critical Imaging System for Outperforming All Competing Products

LONDON, August 31, 2010 – Following a recent analysis of the medical imaging devices market, Frost
& Sullivan presented Lodox Systems (Pty) Ltd (Lodox) with the "2010 South
African Medical Imaging Product Quality Leadership Award". Statscan, Lodox's
digital x-ray product, stunned the market with its ability to produce clear,
diagnostic, whole-body x-ray pictures in just 13 seconds.

[...]

ASP GLOSAIR(TM) Decontamination Technology Undertakes Deep Clean at Royal Liverpool Hospital to Promote Better Patient Care

LONDON, August 31, 2010 – Advanced Sterilization Products (ASP) announced today a partnership with
the Royal Liverpool University Hospital to strengthen their infection
prevention efforts and promote better patient care by utilizing ASP's proven
GLOSAIR(TM) area decontamination technology.

As part of a larger refurbishment project, Royal Liverpool University
Hospital has appointed ASP to perform their [...]

OrthoAccel Technologies Announces Full-Market Release of AcceleDent, a New Technology to Shorten Treatment Time in Braces

HOUSTON, August 31, 2010 – OrthoAccel Technologies, Inc. (www.acceledent.co.uk/home)
announced this week that following a successful limited market release of
AcceleDent last October it will be initiating a full-market release
throughout the United Kingdom this coming September. Availability of
AcceleDent (www.acceledent.co.uk), which is a regulated medical device
and only available to dental professionals to prescribe to their patients,
will be [...]

New Report World Dermatology Market (Drugs, Therapeutic Segments and Disorders) (2010 to 2015) Published By MarketsandMarkets

DALLAS, August 31, 2010 – More than 10,00,000 new cases of skin nonmelanoma cancer has been
reported for the current year only in U.S. This enhanced the market for anti
skin cancer drugs and therapies within the dermatology market. Dermatology
continues to remain one of the promising sectors within the pharmaceutical
market due to recent drug developments in [...]

CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up

The Publication of 10-Year Follow-Up Test Results on the First CYPHER(R) Sirolimus-Eluting Coronary Stent Patient Reveal the Stent's Outstanding Efficacy and Safety

STOCKHOLM, August 31, 2010 – Cordis Corporation, a worldwide leader in the development and manufacture
of interventional vascular technology, announced today at European Society of
Cardiology in Stockholm that the results of follow-up tests undertaken [...]

Glenmark Announces the Discovery of a Novel Chemical Entity ‘GRC 17536′, a TRPA1 Receptor Antagonist, a Potential First-in-Class Molecule Globally

With This Announcement, Glenmark has Clearly Reaffirmed its Position Globally as the Leader in the TRP Space

MUMBAI, India, August 31, 2010 – Glenmark Pharmaceuticals today announced the discovery of a
Novel Chemical Entity(NCE) 'GRC 17536'. The new NCE program is targeting
TRPA1 receptor antagonists for pain and respiratory disorders. TRPA1 belongs
to Transient Receptor Potential (TRP) family [...]

Henry Schein Provides Health Care Products for Relief After Flooding in Pakistan

Company establishes matching relief fund for Pakistan through Henry Schein Cares Foundation

MELVILLE, New York, August 31, 2010 – Henry Schein, Inc. (Nasdaq: HSIC), the largest provider of health care
products and services to office-based practitioners, is working with its non-
governmental organization (NGO) partners – Direct Relief, International
Medical Corps, Americares, and Heart to Heart – to [...]

The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses Now Available at ReportsandReports

DALLAS, Texas, August 31, 2010 – ReportsandReports announces it will carry the The Top 10 Cardiovascular
Device Companies: Market trends, growth strategies, and SWOT analyses Market
Research Report in its store.

Browse the complete Report on:
www.reportsandreports.com/market-reports/the-top-10-cardiovascular-dev
ice-companies-market-trends-growth/
Search More Then 45000 Market Research Reports at ReportsandReports
(www.reportsandreports.com/)
The cardiovascular [...]

ScinoPharm to Invest in Tanvex Biologics

TAINAN, Taiwan, August 31, 2010 – ScinoPharm, a leading active pharmaceutical ingredient (API) developer
and manufacturer headquartered in Taiwan, today announced an investment into
Tanvex Biologics, Inc., a United States company registered in the State of
Delaware. ScinoPharm's investment was in the form of tangible assets,
intellectual properties, as well as cash.

Tanvex specializes in [...]

Sangart, Inc. Reports Positive Phase IIa Data for Novel Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients

Study meets primary endpoint of reducing lactate levels in trauma patients treated with MP4OX

SAN DIEGO, August 31, 2010 – Sangart, Inc., today announced positive results from its Phase IIa
proof-of-concept study of MP4OX (oxygenated pegylated hemoglobin) in severely
injured trauma patients with hemorrhagic shock causing lactic acidosis. The
study demonstrated that MP4OX, when given in addition to [...]

New Data Supports Valdoxan’s(R) Unique Clinical Signature

AMSTERDAM, August 31, 2010 – Valdoxan(R)/Thymanax(R) (agomelatine) is more efficacious than
both conventional selective serotonin reuptake inhibitor (SSRI) and serotonin
noradrenaline reuptake inhibitor (SNRI) antidepressants, according to new
data presented today at the 23rd European College of Neuropsychopharmacology
(ECNP) Congress.

To view the Multimedia News Release, please click:
multivu.prnewswire.com/mnr/prne/valdoxan/44196/
[...]

Teriflunomide Significantly Reduced Annualized Relapse Rate and was Well Tolerated in MS Patients

First Results From the TEMSO Phase III Trial to be Presented During the ECTRIMS Congress in October 2010

PARIS, August 30, 2010 – Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today
that the investigational once-daily oral drug teriflunomide significantly
reduced annualized relapse rate (ARR) at 2 years versus placebo in patients
with relapsing multiple sclerosis (RMS), thus achieving [...]

ATOLL Study Results With Intravenous Enoxaparin in Acute Heart Attack Managed with Urgent Angioplasty

Composite Primary Endpoint: Risk Reduction of 17% (Non-Statistically Significant ) in Death, Complication of Myocardial Infraction, Procedure Failure or Major Bleeding (p=0.07)

PARIS, August 30, 2010 – Pitie-Salpetriere Hospital, Paris, France, August 30th 2010.
The international ATOLL study sponsored by the Assistance Publique – Hopitaux
de Paris showed that enoxaparin reduced the composite of death, complication
of myocardial [...]

From the Laboratory to the Reality of Daily Life

Picture is available via epa european pressphoto agency and can be downloaded free of charge at: https://www.presseportal.de/pm/32079

DUDERSTADT, Germany, August 30, 2010 – Christian Kandlbauer, who lost both of his arms in a high
voltage accident, uses a unique development which until recently sounded
almost like science fiction: An arm prosthesis, the first of its kind in [...]

Elsevier Introduces SciVerse, an Innovative Platform for Accelerating Science

AMSTERDAM, August 30, 2010 -

– Integrates ScienceDirect, Scopus and Targeted Web Content;
Offers New Search and Discovery Applications -

– Opening APIs to Encourage Development of Customized Solutions -

Elsevier, (www.elsevier.com/) a world-leading publisher of
scientific, technical and medical information [...]

DGP Group Rebrands as Intelsius and Announces Launch of New, Innovative Packaging System – Orcatherm(TM)

YORK, England, September 1, 2010 – Formerly DGP Group, Intelsius, a global manufacturer and distributor of
environmentally safe, temperature-controlled and regulatory-compliant
packaging solutions, announced the completion of its corporate rebranding
efforts, including a new corporate identity, logo and redesign of its
flagship website.

The rebranding leverages the strong credibility the company has developed
over the past [...]

Low Installation Rates in Retail Pharmacies Across Europe Increase the Growth Potential of the Pharmacy Automation Systems Market, Finds Frost & Sullivan

LONDON, September 1, 2010 – The pharmacy automation systems market in Europe is experiencing a
tremendous growth spurt. Until recently, most pharmacies have been either
without automation or have employed very basic automation systems. In
response, the adoption rate of automation systems across Europe has been
progressing from basic prescription management systems to advanced medication
pick-up and drug dispensing [...]

Helsinn Announces the Official Opening of its New R&D Centre of Excellence in Dublin

The Minister for Finance, Mr. Brian Lenihan T.D. Today Performed the Official Opening of the Centre Which Will Play a Significant Role in Helsinn Group's Pipeline of New Products

LUGANO, Switzerland, September 1, 2010 – The Swiss pharmaceutical group Helsinn announced the official opening,
performed today by the Minister for Finance, Mr. Brian Lenihan T.D, of [...]

CPM Resource Center’s 19th International Conference to Focus on Sustainable Healthcare Transformation

Annual Conference to be Held Jan. 19-22, 2011, and Focus on Transforming Healthcare Through Evidence-Based Clinical Content, Partnerships and Technology

GRAND RAPIDS, Michigan, September 1, 2010 – CPM Resource Center (CPMRC) (www.cpmrc.com), an Elsevier company
and leader in assisting healthcare organizations improve practice at the
point of care, today announced that its 19th International Conference
(www.cpmrc.com/consortium/conference) will take [...]

Novasep Appoints a New Chairman for its Supervisory Board

Bernard Dubois, Former Aventis Senior VP of Global Industrial Operations Brings a Wealth of Experience to Novasep's Top Management Team

POMPEY, France, September 1, 2010 – Novasep, a leading supplier of manufacturing solutions to the life
science industries, announces the appointment of Bernard Dubois as Chairman of
its supervisory board. Bernard Dubois replaces Pietro Stefanutti, who decided
to [...]

Archimedes Pharma Receives European Marketing Authorisation for PecFent(R) for the Treatment of Breakthrough Cancer Pain

READING, England, September 1, 2010 – Archimedes Pharma Ltd., a leading international specialty
pharma company, today announced that the European Commission has granted
marketing authorisation for its lead product, PecFent*, an innovative
fentanyl nasal spray for the treatment of breakthrough cancer pain (BTCP) in
adults who are already receiving maintenance opioid therapy for chronic
cancer pain.

[...]

US Educational Support Service for MS Community, MS LifeLines(R), Reaches Milestone of Servicing one Million In-bound Calls

GENEVA, September 1, 2010 – Merck Serono, a division of Merck KGaA, Darmstadt, Germany,
announced today that MS LifeLines, a US educational and support service which
includes a call center, has achieved a milestone in servicing one million
in-bound calls since its inception in 2002. MS LifeLines is sponsored by EMD
Serono, Inc. an affiliate of Merck KGaA, [...]

Cancer Center to be the First in Europe to Install a CyberKnife VSI System, the Latest Generation of the CyberKnife System

The Leon-Berard Center of Lyon, France, is now offering its cancer patients the benefits of Full Body Radiosurgery

SUNNYVALE, California, September 1, 2010 – Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of
radiosurgery, today announced that the first CyberKnife VSI System to be
installed in Europe was placed at the Leon-Berard Cancer Multidisciplinary
Center (CLB) [...]

Olivier BOHUON Appointed Chief Executive Officer of Pierre Fabre SA

CASTRES, France, September 1, 2010 – During its first meeting, the Board of Directors of Pierre
Fabre SA chaired by Mr. Pierre Fabre appointed Olivier BOHUON as the
company's Chief Executive Officer.

Olivier BOHUON, 51, has until now been the executive
vice-president of Abbott Corporation and president of its pharmaceutics
division. In this capacity, he [...]

ReproCELL Announces New Line of Services in Neuronal Research Using Human iPS Cells

YOKOHAMA, Japan, September 1, 2010 – ReproCELL, Inc. (CEO: Chikafumi Yokoyama PhD) is pleased to
announce a new line of products to be launched in the autumn of 2010,
offering neuronal cells derived from human iPS (induced pluripotent stem)
cells.

Since April 2009, ReproCELL has been manufacturing iPS
cell-derived cardiomyocytes for drug toxicity testing as [...]

ITC Global Security Announces Board Changes and Senior Appointments

Reinforcing the Executive Management Team to Facilitate Global Expansion
LONDON, September 1, 2010 – Photograph available (www.itcsecurity.com/about-itc/newsroom-and-events/itc-global-security-board-changes-and-senior-appointments )

ITC Global Security (www.itcsecurity.com/about-itc/newsroom-and-events/itc-global-security-board-changes-and-senior-appointments ),
a specialist information security and advanced networking firm, today
announced a Board restructure and new senior appointments. The new structure
consolidates the strengths of the group to support the future direction and
growth [...]

French Laboratoires Thea Acquires the Mydriasert(R) ophthalmic Insert From Carl Zeiss Meditec

CLERMONT-FERRAND, France, September 1, 2010 – Laboratoires Thea, the leading independent ophthalmic group in
Europe, completes its innovative product range with the announcement of the
final acquisition of Mydriasert(R). Mydriasert(R), the 1st mydriatic
ophthalmic insert, is indicated for dilated fundus examination (DFE) or
cataract surgery, the most widely implemented surgical procedure. Regarding
cataract surgery, the market represents close to [...]

PruHealth Set to Grow Following Approval of Standard Life Healthcare Acquisition

LONDON, September 1, 2010 – PruHealth has become a competitor of scale in the UK Private Medical
Insurance (PMI) market following the completion of the acquisition of
Standard Life Healthcare by Discovery Holdings* of South Africa.

The acquisition opens a new chapter in PruHealth's
development, boosting cover to 700,000 lives and market share to [...]

DM Corporation and ORF Genetics to Collaborate on Protein Drugs

An MOU Signed During Official Visit of Mrs. Preneet Kau, Indian Minister of State for External Affairs, to Iceland

REYKJAVIK, Iceland and KOLHAPUR, India, September 1, 2010 – The Indian company DM Corporation and ORF Genetics of Iceland
are to collaborate on the development, production and marketing of protein
drugs. Mr. Dilip Mohite, Chairman and Managing Director [...]

Colorcon Opens Technical Service Laboratory in Istanbul, Turkey

HARLEYSVILLE, Pennsylvania, September 1, 2010 – Colorcon Limited today announced the opening of a new technical service
laboratory in Turkey. Located in Atasehir, the southern area of Istanbul, the
new laboratory contains fully equipped processing suites for laboratory-scale
immediate and modified release film coating trials. The facilities are
available for customer use, operating under the highest standards of
confidentiality [...]

New England Journal of Medicine Study Shows New Molecular TB Test Could Offer Rapid and Effective Diagnosis in Developing Countries

Fast, accurate and easy-to-use TB test could revolutionize diagnosis of a disease that kills nearly two million people annually

GENEVA, September 1, 2010 – A study(1) published in The New England Journal of Medicine today reports
that a new molecular tuberculosis (TB) test, Xpert(R) MTB/RIF, provides
highly sensitive detection of tuberculosis and drug resistance in low
resource settings [...]

Epigenetics Therapeutics to 2017 – High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma Now Available at ReportsandReports

DALLAS, September 2, 2010 – ReportsandReports announces it will carry the Epigenetics Therapeutics to
2017 – High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia,
Multiple Myeloma and Cutaneous T-Cell Lymphoma Market Research Report in its
store.

Browse the complete Report on:
www.reportsandreports.com/market-reports/epigenetics-therapeutics-to-2
017-high-market-potential-for-epig/
Search More Then 45000 Market Research Reports at [...]

MarketsandMarkets New Report – Global Weight Loss and Diet Management Market (2009 – 2014)

DALLAS, Texas, September 2, 2010 – Buy this report now:
www.marketsandmarkets.com/Market-Reports/digestive-health-ingredients-
225.html

(Due to the length of this URL, it may be necessary to copy and paste
this hyperlink into your Internet browser's URL address field. Remove the
space if one exists.)
This market report analyzes the trends prevailing in the
digestive health [...]

iDent Imaging Teams with Objet Geometries to Offer Surgical Guide Solutions For Implant Dentistry

FOSTER CITY, California and REHOVOT, Israel, September 2, 2010 – iDent Imaging Inc., (www.ident-surgical.com/ ) (Foster City, CA) a
leading provider of 3-D surgical planning software and surgical guides for
dental implants, has teamed with Objet Geometries Ltd. (www.objet.com/
) (Rehovot, Israel), innovation leader of 3-Dimensional printing systems, to
improve the quality of dental implant placement. Objet systems [...]

Long Term Data Presented at ESC 2010 Further Support the Benefit of The CYPHER(R) Sirolimus Drug-Eluting Stent Compared to The ENDEAVOR(R) Zotarolimus-Eluting Stent in Important High-Risk Subgroups

Additional Analysis of 18 Month Data of the SORT OUT III Trial Provides Detail on Safety and Efficacy Outcomes in Patients With Diabetes, Acute Coronary Syndrome, or Treatment of Multiple Lesions

STOCKHOLM, September 2, 2010 – Three new analyses of subgroups from the SORT OUT III study
presented at the European Society of Cardiology (ESC) meeting [...]

IBA Sells Prototype of Next Generation Carbon Therapy System

Leader in Proton Therapy Applies Expertise Towards New Technologies in Cancer Treatment

LOUVAIN-LA-NEUVE, Belgium, September 2, 2010 – IBA (Ion Beam Applications S.A.), developer of equipment and
pharmaceuticals dedicated to cancer diagnosis and treatment, announced today
that it has sold the prototype of its next generation carbon therapy system
to the French company CYCLHAD (un CYCLotron pour l'HADronth??rapie, [...]

Manufacturing of Biologics – Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports

DALLAS, Texas, September 2, 2010 – ReportsandReports announces it will carry Manufacturing of Biologics
(www.reportsandreports.com/market-reports/manufacturing-of-biologics-i
ncreasing-demand-for-monoclonal-ant/) – Increasing Demand for Monoclonal
Antibodies and Recombinant Proteins Drives Increases in Capacities and
Innovative Production Technologies Market Research Report in its store.

Browse the complete Report on:
www.reportsandreports.com/market-reports/manufacturing-of-biologics-in
creasing-demand-for-monoclonal-ant/
Search More Then 45000 Market Research Reports at [...]

New and Unique Tool Eases the Process of Finding Article Reviewers

Elsevier Continues to Support the Peer Review Process by Developing a Tool to Help Journal Editors Find Reviewers

AMSTERDAM, September 6, 2010 – Elsevier, a world-leading publisher of scientific, technical and medical
information products and solutions, announced today the launch of a new and
unique tool to help editors find reviewers (
support.elsevier.com/app/answers/detail/a_id/710), which addresses the
number one pain [...]

Diagnostic Imaging Market to 2016 – Nuclear Imaging Systems and Ultrasound Systems to be the key Revenue Generators now Available at ReportsandReports

DALLAS, September 6, 2010 – ReportsandReports announces it will carry Diagnostic Imaging Market to
2016 – Nuclear Imaging Systems and Ultrasound Systems to be the Key Revenue
Generators Market Research Report in its store.

Browse the complete Report on:
www.reportsandreports.com/market-reports/diagnostic-imaging-market-to-
2016-nuclear-imaging-systems-and-u/
(Due to the length of this URL, it may be necessary [...]

Stallergenes and Shionogi Sign Exclusive Partnership Agreements for Immunotherapy Tablets in Japan

ANTONY, France, September 6, 2010 – Stallergenes S.A. has announced today the signing of exclusive
partnership agreements with Shionogi & Co., Ltd. for two sublingual allergen
immunotherapy tablet products resulting from the Stalair(R) program:
Actair(R) house dust mite tablets and Japanese cedar pollen tablets.

With 32 million respiratory allergy sufferers, there is a
strong – [...]

The Harley Medical Group Report Surge in Liposuction Procedures

LONDON, September 8, 2010 – The Harley Medical Group has reported thousands of enquiries for
liposuction over the last month as a wave of what is termed 'beach envy' -
jealousy of other women's bodies – hit holidaymakers.

The rise has been driven largely by 30-plus women, with clinic staff
reporting patient feedback that [...]

Shire Expands Pipeline to Treat Orphan Muscle Diseases Through Collaboration With Acceleron Pharma

Deal Grants Shire Exclusive Ex-North American Rights to Acceleron's Innovative Class of ActRIIB Molecules, Including ACE-031 Currently in Phase 2 Development to Treat Duchenne Muscular Dystrophy

CAMBRIDGE, Massachusetts, September 9, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, today announced the expansion of its Human Genetic
Therapies pipeline through the exclusive license, [...]

MarketsandMarkets: Global Dental Devices and Consumables Market to be Worth $27.6 Billion by 2015

DALLAS, Texas, September 9, 2010 – The dental devices report forecasts the size of global dental devices and
consumables market (
www.marketsandmarkets.com/Market-Reports/dental-device-275.html) over
the period from 2010 to 2015. The report analyses the key trends of the
market, and segments the global dental equipment and consumables market by
components and into various geographic regions (with the market size of [...]

France Must Turn its Strengths into Competitive Advantages on the International Stage – 2 Major Factors for Success: Greater Emphasis on Innovative Technology and Renewed Partnerships

An Exclusive Study by AEC Partners on Behalf of the Leem
PARIS, September 9, 2010 – Is France an attractive investment option for the
international managers of pharmaceutical companies? On what basis? What
concrete measures will enable France to reindustrialise and remain a major
country in pharmaceuticals over the next ten years?

To provide objective [...]

UBM South America Pharma Events Attract Record Attendance

AMSTERDAM, September 9, 2010 – Leading events organiser UBM Live today reported that a record 2356
unique visitors attended its 2010 CPhI South America pharma events,
representing an increase of 17% over 2009 attendance levels, and announced
the dates and location for next years' events, which will be held from 24-26
August, at the Transamerica Expo Center, Sao [...]

Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance

Abbott Leads the Industry in Environmental Management and Climate Policy, Responsible Marketing Practices, Standards for Suppliers, Innovative Philanthropy

ABBOTT PARK, Illinois, September 9, 2010 – Abbott (NYSE: ABT) announced today that it was included on both the Dow
Jones Sustainability World Index and North America Index for the sixth
consecutive year. The Dow Jones Sustainability Indexes (DJSI) [...]

Nucletron Spotlights Innovations During ESTRO29

Exciting New Solutions for Precision Cancer Treatment on Display During ESTRO29 in Barcelona, Spain

VEENENDAAL, The Netherlands, September 10, 2010 – Nucletron, a leading provider of state of the art radiotherapy solutions
for cancer treatment, today announced a large number of exciting innovations
for precise cancer treatment that will be in the spotlight during ESTRO29 in
Barcelona. The [...]

Vandetanib Phase II Trial Shows Significant Improvement of Progression Free Survival in Patients With Advanced Papillary or Follicular Thyroid Cancer

This press release has been made available on worldwide (excluding US) press communication media for the benefit of correspondents writing for the medical professional press. Differing national legislation, codes of practice, medical practice etc mean that you should contact your local AZ press office to obtain information designed for use in your country.

PARIS, September 12, [...]

LORENZ Announces userBridge.10

This Year's User Conference Will be Held in Frankfurt, Germany // New: "eRegulatory Forum" as Top Level Panel Discussion

FRANKFURT, Germany, September 13, 2010 – LORENZ Life Sciences Group, the largest supplier of eCTDs in the world,
announced the final agenda for userBridge.10, their well-established user's
conference, taking place this year from September 21st-23rd in Frankfurt,
Germany. Over [...]

Shire Update on ProAmatine(R) (midodrine HCl)

FDA Posts Clarifying Statement on its Website
PHILADELPHIA, September 13, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces that the United States Food and Drug
Administration today posted an update on its website related to ProAmatine
(known generically as midodrine), a medicine approved for the treatment of
symptomatic orthostatic hypotension. Notably, the FDA [...]

MarketsandMarkets: Magnetic Resonance Imaging (MRI) Global Market Worth US$ 5,844.4 Million By 2015

DALLAS, September 13, 2010 – The 'Magnetic Resonance Imaging (MRI): Advanced Technologies and Global
Forecast (2010 – 2015)' studies the MRI market based on technologies and
applications and analyzes major market drivers, restraints, and opportunities
for the magnetic resonance imaging systems market in North America, Europe,
Asia and ROW (Rest of the World).

Browse market [...]

Edwards Lifesciences Launches Magna Mitral Ease Valve

Preliminary Data on Odyssey Aortic Valve Platform Show Intraoperative Benefits With Rapid Deployment Valve

GENEVA, Switzerland, September 13, 2010 – Edwards Lifesciences Corporation (NYSE:EW), the global leader in the
science of heart valves and hemodynamic monitoring, today announced the U.S.
and European launches of its Carpentier-Edwards PERIMOUNT Magna Mitral Ease
valve, designed to enhance implantation in the challenging [...]

SMC Issues Positive Recommendation on esomeprazole 10mg (Nexium(R)) For Children Aged one to 11 Years old in Scotland With Gastro-Oesophageal Reflux Disease (GORD)

LONDON, September 13, 2010 – AstraZeneca UK welcomes the Scottish Medicines Consortium's (SMC)
positive recommendation for esomeprazole 10mg gastro-resistant granules for
oral solution, sachet (Nexium(R)) for use in children aged one to 11 years
old in Scotland with gastro-oesophageal reflux disease (GORD).(1) The
symptoms of the condition can include the return of food from the stomach
into the mouth, [...]

PRA International’s Drug Safety Experts to Speak at Safety Congress

Key Topic: Global Compliance Challenges
RALEIGH, North Carolina, September 13, 2010 – PRA International, a leading Clinical Research Organization, announces
that two of its leading drug safety experts will present at the 4th annual
World Drug Safety Congress to be held in London 14 -17 September 2010. PRA
will also host a conference exhibit.

Dr. [...]

MyGardenRouteInfo.com Tackles Accessibility Issues at Local Businesses

PORT ELIZABETH, South Africa, September 13, 2010 – MyGardenRouteInfo.com has recently identified serious accessibility
issues at restaurants, accommodation and tourist attractions along the Garden
Route and throughout the Eastern Cape and has endeavoured to offer a
comprehensive resource for tourists with mobility and accessibility issues.

According to Steve Chester, managing director of MyGardenRouteInfo.com,
improving accessibility [...]

The Search is on for Britain’s Worst Snorer to Have a Good Night’s Sleep

GLASGOW, Scotland, September 15, 2010 – Is that the sound of a super car rev waking you up in the
middle of the night? No, it's just your partner snoring….again. Did you
know that snoring can reach up to 100 decibels – loud enough to rattle the
windows and keep the whole street awake!

[...]

Saudi Aramco Selects Press Ganey to Measure, Improve Patient Satisfaction

SOUTH BEND, Indiana, September 14, 2010 – Saudi Aramco has selected Press Ganey to help measure and improve patient
satisfaction at its company-owned and contracted health care facilities.
Press Ganey began working with Saudi Aramco on July 1, 2010.

"Saudi Aramco is committed to raising the well-being of our employees and
is working with [...]

‘Supporting Jobs and Careers in the Community’ is Newest Course Introduced to College of Direct Support Curriculum

ATLANTA, Georgia, September 14, 2010 – The College of Direct Support (CDS) (
info.collegeofdirectsupport.com/), an internet-based college for
Direct Support Professionals (DSPs) that is managed in partnership by
Elsevier I MC Strategies (www.mcstrategies.com/) and the University of
Minnesota's Research and Training Center, has introduced its newest course -
"Supporting Jobs and Careers in the Community."

This [...]

Paris Prepares for CPhI Worldwide; Industry Leading Pharma Event Attendance Expected to Exceed 25,000

AMSTERDAM, September 14, 2010 – Leading events organiser UBM Live today announced that it expects the
attendance for CPhI Worldwide, the annual flagship tradeshow for pharma
ingredients, now in its 21st year and the year being held in Paris, to exceed
the 25,000 seen at last year's event, held in Madrid. Along with co-hosted
events – P-MEC Europe [...]

Torchmark Subsidiary to Sell United Investors Life Insurance Company

MCKINNEY, Texas, September 14, 2010 – Torchmark Corporation (NYSE: TMK) announced that its subsidiary, Liberty
National Life Insurance Company (Liberty), has signed an agreement to sell
its wholly owned subsidiary, United Investors Life Insurance Company (United
Investors), to Protective Life Corporation for a purchase price of
approximately US$316 million, including adjusted statutory capital and
surplus at closing expected to [...]

J. Robert Selman to Be Awarded Grove Medal in Recognition of a Lifetime of Pioneering Work on Fuel Cells

Award to be Presented at the Grove Fuel Cell Science & Technology Conference; Zaragoza, Spain, 6-7 October 2010

OXFORD, England, September 14, 2010 – Elsevier, a world-leading publisher of scientific, technical and medical
information products and services, announced that J. Robert Selman,
University Distinguished Research Professor at the Illinois Institute of
Technology (Chicago, USA) and author of over [...]

Elsevier Appoints Suzanne BeDell as Managing Director, Science and Technology (S&T) Books

BeDell to Lead the Ongoing Transformation of S&T Books From a Traditional Print-Based Book Publisher Into a Technology-Driven, High Quality Content-Based Information Provider

BURLINGTON, Massachusetts, September 14, 2010 – Elsevier, the leading publisher of scientific, technical and medical
information products and solutions, announced today that Suzanne BeDell has
joined Elsevier as Managing Director, S&T Books. BeDell will [...]

Digitron Appoint Gerry Casillas as New US Sales Manager

CALIFORNIA, September 14, 2010 – Digitron, the manufacturer of high quality monitoring instruments for the
food, catering and healthcare industries, has appointed a US sales manager to
grow the brand in North America.

Gerry Casillas is building relationships with distributors and is
establishing a warehouse and customer service department in Thousand Palms,
California.
[...]

MEPs Launch Call to Action for Better Oral Health to Commissioner Dalli

Broad Support to Improve Oral Health Prevention and Access to Dental Care in Europe

BRUSSELS, September 14, 2010 – Dr Thomas Ulmer MEP and Dr Cristian Silviu Busoi MEP marked
the 3rd annual World Oral Health Day by issuing a Call to Action for Better
Oral Health in Europe to John Dalli, European Commissioner for Health and
Consumer [...]

PharmaPendium(TM) Launches Pharmacokinetics Module

Provides Unprecedented Access to Detailed Drug Pharmacokinetics Data and Over 1,000,000 Extracted Exposure Observations From the FDA and EMEA Documents on More Than 2,100 Drugs

NEW YORK, September 14, 2010 – Elsevier today announces that it has significantly increased its service
offering to pharmaceutical R&D professionals with the launch of a new
Pharmacokinetics Module of PharmaPendium(TM), the [...]

New Corporate Website Launched With Focus on Drug Discovery, Life Science Research, & Bioassays/Tests

SUNNYVALE, California, September 14, 2010 – Molecular Devices, Inc. today announced the launch of its new corporate
website. The infrastructure of the new site is focused on its three main
audience segments: Drug Discovery Scientists (BioPharma), Life Science
Researchers (BioResearch), and Bioassay/Test Developers (BioTesting).

(Logo: photos.prnewswire.com/prnh/20100406/SF82092LOGO)
(Logo: www.newscom.com/cgi-bin/prnh/20100406/SF82092LOGO)

[...]

Large Medical Center in South Africa Delivers High-Bandwidth Data Using RADWIN’s Wireless Network

RADWIN's Links Transfer Massive Amounts of Data & X-rays in Seconds Over Wireless Network

TEL AVIV, Israel, September 15, 2010 – RADWIN (www.radwin.com), the global provider of Backhaul and
Broadband Wireless Solutions, today announced that Jackpersad & Partners
Radiology Inc., a state-of-the-art radiology center serving hospitals and
clinics in the KwaZulu-Natal province of South Africa, deployed RADWIN's
wireless links. [...]

Diaceutics and London Genetics Partner to Accelerate Biomarker Development in the Global Biopharmaceutical Industry

WASHINGTON and LONDON, September 15, 2010 – Diaceutics Limited (www.diaceutics.com) and London Genetics
Limited, an expert in the use of pharmacogenetics in clinical drug discovery
and development, today announce a strategic partnership to develop software
decision tools that will provide biopharmaceutical companies with rapid and
extensive access to the world's leading academic biomarker research groups.
The new tools will [...]

Amira Pharmaceuticals Named One of Most Promising Biotech Companies by FierceBiotech’s Annual Fierce 15

SAN DIEGO, September 15, 2010 – Amira Pharmaceuticals, Inc. today was named one of the most promising
biotech companies by FierceBiotech through its annual list, the Fierce 15.

Every year FierceBiotech evaluates hundreds of private companies for its
annual list, which is based on a variety of factors such as the strength of
its [...]

Tunnell Consulting Forms Strategic Alliance With Ireland-Based Campbell Informatics

Firms to provide enhanced solutions to life sciences organizations globally
KING OF PRUSSIA, Pennsylvania, September 15, 2010 – Tunnell Consulting, Inc. announced today that it has entered into a
strategic alliance with Campbell Informatics, an integrated services and
technology company based in Cork, Ireland. The alliance of Tunnell, a leading
life sciences industry consultancy, and Campbell, a provider [...]

MarketsandMarkets: Global Minimally Invasive Surgery (MIS) Market Worth US$ 90.4 Billion by 2015.

DALLAS, Texas, September 16, 2010 – The 'Global Minimally Invasive Surgery Market (2010 – 2015)'
(www.marketsandmarkets.com/Market-Reports/minimally-invasive-276.html)
analyzes the MIS market by products, applications, technologies and studies
the major market drivers, restraints, and opportunities for the minimally
invasive surgery market in the U.S., Europe, APAC and ROW (Rest of the
World).

Browse market data tables and in-depth [...]

Transcatheter Technologies Successfully Performs in Vivo Implantation of the Trinity Transapical Aortic Valve System

Transapical Implantation of a Percutaneous Aortic Tissue Valve Validates Trinity's Technology

REGENSBURG, Germany, September 16, 2010 – Transcatheter Technologies GmbH (TT), an innovative medical device
company that is developing a second-generation transcatheter aortic valve
prosthesis, announced today that its proprietary transapical aortic valve has
been successfully implanted in the acute porcine model.
The acute in [...]

ResMed Launches Smaller Alternative to the Full Face Mask for CPAP Treatment

Introducing Quattro FX, ResMed increases choice and comfort for sufferers of sleep apnoea

OSLO, Norway, September 16, 2010 – ResMed (NYSE: RMD), a leading developer, manufacturer, and distributor of
sleep and respiratory medical equipment today announced the launch of Quattro
FX Full Face Mask, a smaller alternative to the full face mask for use with
positive airway pressure [...]

Study Shows ResMed’s New CPAP Device Increases Patient Compliance

Clinical study confirms new features of S9 Series prolong patients' sleep by up to 30 minutes

OSLO, Norway, September 16, 2010 – ResMed (NYSE: RMD), a leading developer, manufacturer, and distributor of
sleep and respiratory medical equipment today announced the results of a
clinical study confirming that patients' compliance with sleep therapy
increases when using the ResMed's new [...]

Abbott to Present Data on Market-Leading XIENCE V(R) and Promising Vascular Pipeline at TCT 2010

ABBOTT PARK, Illinois, September 16, 2010 – — XIENCE V Data From the SPIRIT IV Trial to be Presented as a Late
Breaking Trial on Sept. 23

— Abbott's Vascular Pipeline Presentations to Include Data on the
MitraClip(R) System and the Bioresorbable Vascular Scaffold
Abbott (NYSE: ABT) today announced the [...]

CID to Update Interventional Cardiologists on Their Drug Eluting Stent Program at TCT 2010

WASHINGTON,, September 16, 2010 – CID s.r.l., a European company leader in interventional medicine, will
update interventional cardiologists on the status of their revolutionary drug
eluting stent technology during The Drug Eluting Stent (DES) Summit at TCT
2010, Washington, DC on Wednesday, September 22, 2010. The lecture, entitled
"Status of the CID Cre8 polymer-free DES program", will be [...]

New Combination for Asthma Shows Encouraging Results in Delivering Efficacy and Fast Onset of Action

CAMBRIDGE, England, September 19, 2010 – Data presented at the European Respiratory Society (ERS) congress
demonstrate that a new fixed-dose combination therapy of fluticasone
propionate (FP), an inhaled corticosteroid, and formoterol fumarate (FORM), a
long-acting beta2-agonist, is as effective in treating asthma as one of the
current market leaders in Europe, fluticasone propionate/salmeterol xinafoate
(FP/SAL), but has a more [...]

AQT90 FLEX Opens Up for a New and Better Way of Measuring Troponin T at the Point of Care

COPENHAGEN, September 20, 2010 – Radiometer has added the cardiac marker Troponin T* (TnT) to its AQT90
FLEX immunoassay analyzer for the use at the point of care. According to
Radiometer President Peter Kurstein, the new marker enables healthcare
professionals to improve processes in emergency rooms and labs, ultimately
helping hospitals improve patient care and reduce costs.

[...]

24-Week Phase 3 Study Found Investigational Drug Dapagliflozin Improved Glycosylated Hemoglobin (HbA1c) When Added to Glimepiride in Adults With Type 2 Diabetes Mellitus

STOCKHOLM, September 20, 2010 – Bristol-Myers Squibb Company (NYSE: BMY)(www.bms.com) and
AstraZeneca (NYSE: AZN)(www.astrazeneca-us.com)
today announced results from a randomized, double blind Phase 3 clinical
study, which demonstrated that the addition of the investigational drug
dapagliflozin to existing glimepiride (sulphonylurea) therapy produced
significant reductions in glycosylated hemoglobin levels (HbA1c) in adult
patients with type 2 diabetes compared to glimepiride [...]

Sanofi-aventis: Investigational Compound Once-Daily Lixisenatide Demonstrated Significant Improvement in Glucose Control in Patients With Type 2 Diabetes

Phase III Study Results Also Demonstrated the Therapy had Acceptable Safety Profile

PARIS, September 20, 2010 – Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today
the first Phase III results of the GetGoal clinical trial program assessing
the efficacy and safety of lixisenatide, a once-daily GLP-1 receptor agonist,
as monotherapy in patients with type 2 diabetes. These results [...]

Three Million Give ‘Thumbs Up’ to Saving Children’s Lives

Claire Danes to unveil unique visual petition in Grand Central Terminal on Monday 20th September, 1300 hrs

NEW YORK, September 20, 2010 – Emmy award-winning actress Claire Danes will join millions of people
who've added their thumbprints to an innovative and unique global petition at
Grand Central Terminal, lead by global humanitarian organisation Save the
Children.
[...]

CareFusion Launches Next-Generation Clinical Diagnostics Software for Jaeger(TM) and SensorMedics(R) Product Lines

HOCHBERG, Germany, September 20, 2010 – CareFusion (NYSE: CFN), a leading, global medical device company, today
announced the commercial release of SentrySuite(TM), the next-generation
clinical diagnostics software for the Jaeger(TM) and SensorMedics(R)
Pulmonary Diagnostics and CardioPulmonary Diagnostics instruments.

SentrySuite is an innovative set of software applications to assist with
clinically intelligent diagnostics to improve the [...]

Boston Scientific Receives Exclusive Expanded Indication for its CRT-Ds

FDA Approval is Based on Results From the Company's Landmark MADIT-CRT Trial

NATICK, Massachusetts, September 20, 2010 – Boston Scientific Corporation (NYSE: BSX) today announced that
the U.S. Food and Drug Administration (FDA) has approved an expanded
indication for its cardiac resynchronization therapy defibrillators (CRT-Ds),
including the COGNIS(R) CRT-D. The exclusive expanded indication is effective
immediately and makes Boston [...]

Sanofi-aventis: Adding Lantus(R) to Oral Antidiabetic Drug Therapy Further Reduced Blood Sugar in Patients With Type 2 Diabetes

Findings Presented at European Association for the Study of Diabetes (EASD) 46th Annual Meeting

PARIS, September 20, 2010 – Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today
results of two studies presented at the European Association for the Study of
Diabetes (EASD) 46th Annual Meeting in Stockholm, Sweden. The first pooled
analysis using patient-level data from randomized clinical [...]

Parents Putting Their Children at Risk due to Poor Diagnosis of Serious Illnesses

Millions of Parents are not Confident About Taking Their Child's Temperature

LONDON, September 20, 2010 – Three quarters of parents aren't confident about diagnosing illness in
their own children, according to results of a new survey released today.
Worryingly, nearly half of the parents surveyed aren't aware of the
normal body temperature range of [...]

Daxas(R) (roflumilast) Data Analysis Shows Reduction in Harmful Lung Attacks

ZURICH, September 20, 2010 -

– Global Survey Published Today Shows Long-Term Impact of Exacerbations
Seriously Underestimated[1]

– More Than Three Quarters of Patients Surveyed Suffer From
Exacerbations[1]

– New Data Analysis Released at ERS [...]

Heads of State, Leading CEOs, Entrepreneurs and World-Renowned Artists Gather in New York City From September 22-23 for the 2010 Blouin Creative Leadership Summit

NEW YORK, September 20, 2010 – The Louise Blouin Foundation (LBF) is pleased to announce the fifth
annual Blouin Creative Leadership Summit (BCLS), a forum in partnership with
the United Nations Office of Partnerships that engages in dialogue and
exchanges best practices to successfully confront the challenges and
opportunities brought about by globalization over the coming decade.

[...]

Nonin Medical to Introduce New Innovations at ERS 2010 Annual Congress

Next-Generation Wrist-Worn Pulse Oximeter, Disposable Sensors, Pulse Oximetry Clinical Guidebook, European Center Unveiled at Booth #C.100

MINNEAPOLIS, September 20, 2010 – Nonin Medical, Inc., a leading innovator of noninvasive physiological
monitoring solutions, today introduced new pulse oximetry products, a new
clinical guidebook and a new European sales, distribution and customer
service center at the European Respiratory Society (ERS) [...]

AMT’s EGM Passes All Resolutions and Strengthens Supervisory Board With Joseph Feczko, Steven Holtzman and Francois Meyer

AMSTERDAM, September 20, 2010 – Amsterdam Molecular Therapeutics (AMT) Holding N.V. (Euronext: AMT), a
leader in the field of human gene therapy, announced today that its
Extraordinary General Meeting of Shareholders passed all resolutions set out
in the Notice of the Meeting dated August 9, 2010, including an increase of
the authorized capital and the appointments of Dr. [...]

Kinetic Systems Appoints Peter M. Maris President & Chief Executive Officer

DURHAM, North Carolina, September 20, 2010 – Kinetic Systems, Inc., a leading global provider of process and
mechanical solutions to electronics, biopharmaceutical and general industry
clients, announced today the appointment of Peter M. Maris as President and
Chief Executive Officer as well as to its Board of Directors. He will also
continue to oversee the International Operations division.

[...]

Talecris Biotherapeutics GmbH Awards Winners of the 7th Annual European ALTA Research Fellowship at 2010 ERS Meeting

Awards fund early career investigators' research to advance understanding and potential treatments of alpha1-antitrypsin deficiency

BARCELONA, Spain, September 20, 2010 – Talecris Biotherapeutics GmbH announced yesterday the recipients of the
2010 European alpha1-antitrypsin Laurell's Training Awards (eALTA). The
annual awards, sponsored by Talecris, provide two fellowships of euro 50,000
to young investigators whose research aims to enhance the [...]

NewBridge Pharmaceuticals Completes US$12 Million First Close of Series B Financing, Announces Senior Executive Appointments

DUBAI, United Arab Emirates, September 20, 2010 – NewBridge Pharmaceuticals FZ-LLC of Dubai, UAE announced today that
Joseph W. Henein has been appointed President and Chief Executive Officer and
a member of the company's Board of Directors. Mr. Henein is a senior
executive who joins NewBridge after a career extending over 29 years in
multinational pharmaceutical corporations, holding [...]

Antidyslipidemics Market Forecast now Available at ReportsandReports

DALLAS, September 21, 2010 – ReportsandReports announces it will carry Antidyslipidemics Market
Forecast Research Report in its store.

Browse the complete Report on:
www.reportsandreports.com/reports/7193-antidyslipidemics-market-foreca
st.html
(Due to the length of these URLs, it may be necessary to copy and paste
the hyperlinks into your Internet browser's URL address field. Remove the
space if [...]

immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio

New Investment Allows immatics to Perform Pivotal Study With its Lead Vaccine IMA901 in Patients With Renal Cell Carcinoma (RCC) – Study to Start in 2010

TUEBINGEN, Germany, September 21, 2010 – immatics biotechnologies GmbH, a biopharmaceutical company
developing advanced therapeutic vaccines that are active against cancer,
announced today that it has raised EUR53.8million in a Series [...]

PROMUS(R) Element(TM) Stent Approved for Use in Diabetic and Heart Attack Patients in CE Mark Countries

NATICK, Massachusetts, September 21, 2010 – Boston Scientific Corporation (NYSE: BSX) today announced that
its PROMUS(R) Element(TM) Everolimus-Eluting Coronary Stent System has
received CE Mark approval for use in patients with diabetes[1] and those
experiencing an acute myocardial infarction (AMI), or heart attack.

"We are pleased to receive these expanded indications for the
high-risk diabetic [...]

Wake Up and Find the Coffee With Macmillan’s Free iPhone App

…and Why Not Donate the Price of One Whilst You Sip Away!
LONDON, September 21, 2010 – The Macmillan Coffee Finder is a new free app from Macmillan Cancer
Support to help people find the best cup of coffee nearest to them. Starting
off with over 900 caf??s and coffee shops reviewed and rated around the UK,
users [...]

Almac’s Clinical Technologies Division Undergoes Successful Joint GCP-GMP MHRA Inspection

YARDLEY, Pennsylvania, September 21, 2010 – Almac's Clinical Technologies division announced today that it had
successfully passed one of the UK's first joint routine GCP/GMP Medicines and
Healthcare Products Regulatory Agency (MHRA) inspections at its Craigavon, UK
site. This involved senior MHRA inspectors from both its GCP and GMP areas
assessing compliance with UK and European legislation.

[...]

Extensi??n del programa mundial de estudios cl??nicos de la vacuna contra el dengue de Sanofi Pasteur a Brasil

Un nuevo estudio para acelerar el desarrollo de una vacuna innovadora contra el dengue, en uno de los pa??ses m??s afectados del mundo

SAO PAULO, September 21, 2010 – Sanofi Pasteur, la divisi??n vacunas del Grupo Sanofi-aventis,
anunci?? hoy el inicio de un nuevo estudio cl??nico con ni??os y adolescentes,
en Brasil, dentro del programa de desarrollo [...]

The European Social Fund Makes News

BRUSSELS, September 22, 2010 – If you're seeking a strong human interest story, then take a
look at the European Social Fund. Far from being a set of dry statistics, the
ESF is the framework for thousands of fascinating tales of individual human
endeavour.

To view the Multimedia News Release, please click:
[...]

Alberto Grua Head of Gr??nenthal Europe and Australia

MILAN, September 22, 2010 – After having handled the worldwide launch of tapentadol, the innovative
drug for the severe acute pain, Alberto Grua has been appointed Gr??nenthal
Europe and Australia Executive Vice President. Beyond the responsibility of
the Gr??nenthal subsidiaries Gr??nin both continents, Grua will be also a
member of the Group Operating Committee of Gr??nenthal Corporation.

[...]

Santaris Pharma A/S Advances miravirsen, the First microRNA-Targeted Drug to Enter Clinical Trials, Into Phase 2 to Treat Patients Infected With Hepatitis C Virus

Santaris Pharma A/S initiates Phase 2a clinical trial with miravirsen (SPC3649) to assess safety and tolerability in treatment-naive patients with chronic Hepatitis C

HOERSHOLM, Denmark and SAN DIEGO, September 22, 2010 – Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused
on the discovery and development of RNA-targeted therapies, today announced
that it has advanced miravirsen (SPC3649), the [...]

World First in Eczema Treatment

LONDON, September 22, 2010 – Following five years of research and development, Dreamskin Health Ltd is
proud to have launched the world's first range of hydrating, medical-grade
silk garments designed to relieve the itching and irritation of eczema and
dermatitis.

The secret to the new garments is a proprietary biomimetic copolymer
matrix which is firmly [...]

Elsevier Launches International Journal of Surgery Case Reports

New Journal, Included in PubMed Central, Publishes Case Reports Only and Through an Author Pays Model

OXFORD, England, September 22, 2010 – Elsevier, the world-leading publisher of scientific, technical
and medical information products and services together with Surgical
Associates Ltd the Owner of the International Journal of Surgery, announced
today the launch of the International Journal of Surgery [...]

Boston Scientific Announces Clinical Data Supporting Safety and Efficacy of Platinum Chromium Promus Element(TM) Stent

Nine-month Results From PLATINUM Clinical Program Presented at TCT
NATICK, Massachusetts, September 22, 2010 – Boston Scientific Corporation (NYSE: BSX) today announced data
from its PLATINUM QCA study, which is designed to evaluate the Company's
PROMUS Element(TM) Everolimus-Eluting Platinum Chromium Coronary Stent. The
results provided 30-day and nine-month clinical outcomes and nine-month
quantitative coronary angiography (QCA) and intravascular ultrasound [...]

Abbott’s Fully Bioresorbable Vascular Scaffold Technology Continues to Demonstrate Strong Clinical Results

Positive Data at Six and Nine Months Affirm Groundbreaking Potential of Abbott's Bioresorbable Vascular Scaffold as a Promising Alternative to Coronary Stenting

ABBOTT PARK, Illinois, September 22, 2010 – Abbott (NYSE: ABT) today announced positive nine-month results from the
first 45 patients enrolled in the second stage of the ABSORB trial. At nine
months, Abbott's bioresorbable vascular [...]

Data Published Today Reveal That Novel Oral Therapy Fostamatinib Demonstrates Positive Response in Rheumatoid Arthritis Patients

Phase II Study Published in the New England Journal of Medicine
LONDON and SAN FRANCISCO, September 22, 2010 – AstraZeneca's (LSE: AZN) new oral syk inhibitor, fostamatinib (R788),
recently in-licensed from Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL),
significantly improved outcomes of patients with rheumatoid arthritis (RA)
who responded inadequately to ongoing treatment with methotrexate (MTX),
according to phase II study [...]

Clinical Genomics Pty Ltd and The Garvan Institute of Medical Research Enter into Licensing Agreement

SYDNEY, September 27, 2010 – Clinical Genomics Pty. Ltd (Sydney, Australia) and The Garvan Institute
of Medical Research (Sydney, Australia) today announced that they have
entered into a license agreement in relation to novel biomarkers discovered
by scientists at the Garvan Institute. Under the terms of the agreement,
Clinical Genomics obtains worldwide exclusive rights to the Garvan's
proprietary cancer [...]

Announcing the Inaugural ACS Careers’ Virtual Career Fair in Conjunction with Informex and C&EN

100% Virtual Show in November Will Facilitate Networking Opportunities, Deliver Educational Content and Connect Employers with Potential Employees

PRINCETON, New Jersey, September 27, 2010 – The American Chemical Society, Informex, and Chemical & Engineering News
(C&EN) announced today that they are to partner in hosting the 'ACS Careers
Virtual Career Fair in conjunction with Informex and C&EN' [...]

Amira Pharmaceuticals Announces IND Submission for Novel LPA1 Antagonist, AM152, for Potential Use in Fibrotic Diseases

SAN DIEGO, September 27, 2010 – Amira Pharmaceuticals, Inc. announced today that it has submitted an
Investigational New Drug (IND) application to the US Food and Drug
Administration (FDA) for AM152, a novel LPA1 antagonist. If accepted, the IND
will enable Amira to begin Phase 1 safety studies with the compound in
healthy subjects.

"We [...]

Trehalose Confirmed to Inhibit Fat Cell Hypertrophy

New Possibility in Metabolic Syndrome Prevention amid Global Spread of High-fat and High-calorie Diet -

OKAYAMA, Japan, September 29, 2010 – Hayashibara Biochemical Laboratories, Inc. based in Okayama City, Okayama
Prefecture, Japan, has confirmed that the naturally-derived functional
saccharide trehalose has the effect of inhibiting fat cell hypertrophy. The
finding will be presented to the 31st conference of [...]

A Happy Coffin Before You Die

Nursing home residents and designers celebrate the art of dying
SINGAPORE, September 28, 2010 – There are some Happy Coffins from Singapore challenging death's taboos.
Today, designer coffins deck a nursing home where three residents fulfill
their pre-departure wishes of how their final resting places should be.

(Photo : www.prnasia.com/sa/2010/09/24/20100924505419.html )
[...]

AstraZeneca UK Receives Positive Decision For Seroquel XL(R)[Black Triangle Drug] (Quetiapine Prolonged Release) as an Add-On Treatment of Major Depressive Disorder

Quetiapine Prolonged Release Becomes the Only Atypical Antipsychotic Approved for Major Depressive Disorder (MDD) as Adjunctive Therapy, and as Monotherapy for Acute Depressive Episodes Associated With Bipolar disorder.

LONDON, September 28, 2010 – AstraZeneca UK is delighted to announce that it has today
received UK approval for Seroquel XL(R)[Black Triangle Drug] (quetiapine
prolonged release) as an add-on [...]

Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports

DALLAS, September 28, 2010 – ReportsandReports announces it will carry Emerging Cancer Vaccines
Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Research
Report in its store.

Browse the complete Report on:
www.reportsandreports.com/reports/33665-emerging-cancer-vaccines-
forecasts-developments-and-pipeline-an.html
Search More Than 50000 Market Research Reports at ReportsandReports
(www.reportsandreports.com/)
Browse All Kalorama Information Research Reports at
www.reportsandreports.com/Publishers/kalorama-information
[...]

National Spa Week Delivers Real Value to the Consumer

LONDON, September 28, 2010 – National Spa Week, now in its 6th successful year, officially ran from
20th – 26th September and has been every bit the success as previous years
providing a wide range of deals, discounts and special offers from around 200
independent spa venues nationwide – which means that Spa Week provides
something for everyone, [...]

Elsevier Survey Reveals Researchers Ready to Push Scientific Search and Discovery to the Next Level

AMSTERDAM, September 28, 2010 – Elsevier, a world-leading publisher of scientific, technical and medical
information products and services, today released highlights from a new
survey that reveals researchers around the globe are not only ready for the
next phase in search and discovery, but also prepared to actively contribute
to making it a reality.

In [...]

Pieris Signs Broad Collaboration With Sanofi-Aventis and Sanofi Pasteur to Develop Anticalin Therapeutics

FREISING-WEIHENSTEPHAN, Germany, September 28, 2010 – Pieris AG (www.pieris-ag.com/) announced today the signature of a
collaboration and license agreement with both Sanofi-Aventis and Sanofi
Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and
NYSE: SNY), under which Pieris will apply its proprietary Anticalin
technology to discover novel Anticalin drugs against multiple targets, with
further development undertaken by [...]

Why Not Give Yourself a Quick Boost?

Put the 'Fizz-Factor' Into Your Life!
LONDON, September 28, 2010 – Fans of Berocca, the UK's No 1 branded energy, vitamin and
mineral supplement will be excited to hear that a new product Berocca Boost
is being launched to help give you a 'little kick when you need it'!

Berocca Boost is the UK's [...]

Apligraf(R) Approved by Saudi Food and Drug Authority for Treatment of Chronic Wounds

Diabetic Foot Ulcers a Widespread and Growing Problem in Gulf States
CANTON, Massachusetts, September 28, 2010 – Organogenesis, Inc. announced that its Apligraf(R) bilayered living
cellular construct has been approved for the treatment of diabetic foot
ulcers and other chronic wounds by the Saudi Food and Drug Authority (SFDA)
of the Kingdom of Saudi Arabia. Apligraf is a [...]

Luminex to Host MAGPIX Road Shows Throughout the U.S. and Europe

MULTINATIONAL TOUR TO SHOWCASE CAPABILITIES OF NEW MULTIPLEXING INSTRUMENT
AUSTIN, Texas, September 28, 2010 – Luminex Corporation (Nasdaq: LMNX), today announced the initial dates and
locations for the MAGPIX(R) road show, a multinational tour designed to
showcase the recently-launched MAGPIX analytical instrument that is capable
of performing up to 50 tests on a single sample and providing nearly [...]

Media Advisory – Prime Minister of Kenya to Open Eye Unit at Kitale District Hospital

CALGARY, Canada, September 28, 2010 -

What: KITALE HOSPITAL INAUGURATION
The grand opening of the eye clinic at the Kitale District
Hospital, which which will provide high quality, sustainable eye
[...]

New IonWorks Barracuda Automated Patch Clamp System Meets Need for Affordable, Accelerated Screening of Ligand- & Voltage-Gated Ion Channels Via Direct Electrophysiology Assays

Ideal technology for cardiovascular, metabolic, central nervous system, immune function, and other drug discovery programs

SUNNYVALE, California, September 28, 2010 – Molecular Devices, Inc., a leader in bioanalytical systems for drug
discovery & development, life science research, and bioassay/test
development, today announced that it is taking orders for its new IonWorks
Barracuda(TM) Automated Patch Clamp System.

[...]

Sheffield Bio-Science Adds Chemically Defined Media Supplements to Product Portfolio

BELOIT, Wisconsin, September 28, 2010 – Sheffield Bio-Science, a Kerry Group Business, has formed a strategic
global sales and marketing alliance with Girus Life Sciences. Under this
partnership, Sheffield Bio-Science will be the exclusive Global Sales,
Distribution and Development Partner for Girus Life Sciences' chemically
defined Regocel supplements.

Regocel supplements are small molecule yield enhancers [...]

FCA Carer Recruitment Targets Buckinghamshire, Hampshire and Dorset

BROMSGRAVE, England, September 29, 2010 – Foster Care Associates (FCA), the UK's leading independent fostering
agency, has stepped up its foster carer recruitment campaign across
Buckinghamshire, Hampshire and Dorset.

Through a wide range of marketing initiatives across the print, radio and
online mediums, together with regular information evenings, the agency hopes
to attract a new [...]

Simbionix Receives FDA Clearance to Take Medical Simulation Technology One Step Further Into Clinical Settings

CLEVELAND, Ohio, September 29, 2010 – Simbionix Ltd., a subsidiary of Simbionix USA Corporation, the world's
leading provider of medical education and simulation technology, is proud to
announce the receipt of FDA clearance for the PROcedure Rehearsal Studio(TM)
Software.

The PROcedure Rehearsal Studio software is intended for use as a software
interface and image segmentation [...]

Boston Scientific Welcomes Publication of Analysis Demonstrating Long-Term Survival Benefit for ICD Therapy

MADIT II Eight-Year Outcomes Analysis Shows That One Life is Saved for Every Eight Patients Who Receive an ICD

NATICK, Massachusetts, September 29, 2010 – Boston Scientific Corporation (NYSE: BSX) today welcomed the
publication of an analysis of long-term data from the MADIT II clinical trial
in the current issue of Circulation. The analysis demonstrates that the
life-saving [...]

ASEBIO Requests the Alignment of Spain With the European Union’s Future Strategy of Bioeconomy

PAMPLONA, Spain, September 29, 2010 – The figures regarding BioSpain 2010 have beaten all previous
records, to the extent that it has become the most important event in
biotechnology in southern Europe. "Investment in Biotechnology and in R&D+i
is crucial in order to prevent our best researchers from moving abroad",
warned Jose Maria Fernandez Sousa, president of ASEBIO [...]